AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
ASIX

AdvanSix Inc. Common Stock (ASIX) fair value

Basic Materials · Chemicals · NYSE · United States
$15.71+0.19%
Market cap $424MNext earnings 2026-11-04Updated Oct 18, 2026
Add earnings to calendarGoogle
Our verdict
Trades 53% below our fair value
Price
$15.71
Model fair valueConfidence: good
$33.69
Model range
$7.52 to $48.09
Fair value $33.69
Price $15.71
4 models fit AdvanSix Inc. Common Stock and they disagree: 1 of 4 land within 15% of the average.
Two or more of our models back this value.
Large discount(i)Bronze47
Valued as a cyclical company: P/E comparison, EV/EBITDA comparison, Discounted cash flow, and Graham number.
ACCE opinionAdvanSix Inc. Common Stock (ASIX)
Fair value (4 models)
$33.69
ACCE price target
$16.00
Rating
Undervalued
Horizon
12 months
Fair value published on 18 Oct 2026, 17:04 CEST; previously $33.28 since 14 Oct 2026, 00:00 CEST.
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Rating published on 18 Oct 2026, 17:04 CEST.
Price used: $15.71 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
53.4% below
+114.5% to fair value
ACCE score
26
out of 100
Analysts
50% buy
2 covering
1-year return
-22.3%
Dividend yield
4.08%

AdvanSix Inc. Common Stock in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

AdvanSix makes nylon 6 resins and caprolactam, along with ammonium sulfate fertilizer and other specialty chemicals, primarily from its Hopewell, Virginia and Chesterfield operations. The core of the business is a commodity chain tied to benzene, cyclohexane and ammonia feedstocks, so earnings swing with petrochemical spreads and there is little pricing power to lean on. Its gross margin of 7.3% and operating margin of 2.1% sit at the thin end of the chemicals group, and return on equity is slightly negative at -2.2%, which is the main reason the name scores poorly here. Revenue growth of 2.7% is positive but modest, and with no trailing or forward earnings multiple available, valuation has to be built from cash flow and asset value rather than read off a P/E. The stock is small, at roughly $446M market capitalization, and sits outside major indices, so it is a candidate for a deeper look only if spread recovery in nylon and fertilizer is the thesis you want to test.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 4 flagsAI-assisted·How I use AI
  • high
    Earnings collapse year over year
    Earnings fell 89.6% year over year while revenue grew only 2.7%. Net margin is -1.1% and ROE is -2.2%, so the profit base is thin and shrinking.
  • high
    ACCE score collapsed
    The ACCE score dropped 22 points in 90 days, from 48 to 26, with Growth at 19 and Momentum at 17. Deterioration is broad across factors.
  • moderate
    Free cash flow near zero
    Free cash flow is only $6M against a $428M market cap and a 0.47 debt-to-equity ratio. The balance sheet has little room for a downturn.
  • moderate
    Operating margin thin
    Operating margin is 2.1% on a 7.3% gross margin, leaving little cushion if input costs or volumes move against the company.

AI research notes

AI-assisted·How I use AIWritten Oct 21, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Revenue grew 2.7% year over year, and the five-year average is 5.6% per year.
  • The stock trades at a 6.6x forward P/E against a sector median of 17.6x, and the consensus model fair value sits at $33.69.
  • The 4.0% dividend yield pays shareholders while they wait for the business to recover.
Why it could disappoint
  • Net margin is -1.1% and return on equity is -2.2%, so the company is not yet earning a profit on its shareholders' money.
  • Free cash flow over the last 12 months was only $6M, a 1.5% yield at the current price.
  • The latest earnings per share missed expectations by 75.0%, with 0.14 reported against 0.56 expected.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 4, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where ASIX's valuation models land
Price
$15.71
Model fair value
$33.69
Model range
$7.52 to $48.09
Fair value $33.69
Price $15.71
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
EV/EBITDA comparison
Graham number
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Mixed50% buy · 2 covering analysts
● Strong buy 1● Buy 0● Hold 1● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-4.0%
1 month
-5.0%
3 months
-25.4%
6 months
-32.9%
YTD
-9.2%
1 year
-22.3%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
18 Oct 2026, 17:04 CESTFair value$33.69$33.28$16.37
18 Oct 2026, 17:04 CESTRatingUndervaluedfirst publication$16.37
15 Oct 2026, 00:00 CESTACCE price target$16.00first publication$16.63
14 Oct 2026, 00:00 CESTFair value$33.28$4.00$16.20
29 Sept 2026, 00:00 CESTFair value$4.00$3.92$15.80
26 Sept 2026, 00:00 CESTFair value$3.92$4.17$15.75
24 Sept 2026, 00:00 CESTFair value$4.17$3.97$16.72
21 Sept 2026, 00:00 CESTFair value$3.97$4.08$16.21
18 Sept 2026, 00:00 CESTFair value$4.08$4.01$16.63
16 Sept 2026, 00:00 CESTFair value$4.01$4.10$16.33

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full ASIX page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth19Value41Quality27Momentum17Total26
Valuation
Trailing P/E
no data
Forward P/E
6.6x
PEG
no data
P/B
0.56x
EV / Revenue
0.6x
Book value/sh
$29.51
Enterprise value
$863M
Profitability
ROE
-2.2%
FCF yield
1.51%
ROIC
3.4%
Health and risk
Debt / equity
0.47
Dividend yield
4.08%
Beta
1.34

Price

-21.8% · 1Y

Ask anything about ASIX

Answered from AdvanSix Inc. Common Stock fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
ROEbetter than 83% of peers
low -549%-2%high 7%
Div yieldbetter than 83% of peers
low 0.0%4.1%high 5.8%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
ASIX AdvanSix Inc. Common Stock $15.71$3453% below--2.2%2726
VHI Valhi Inc. Common Stock$14.32----3.0%3248
RYAM Rayonier Advanced Materials Inc. Common Stock$6.70----49.7%1735
BAK Braskem SA ADR$1.70----548.8%2649
TROX Tronox Holdings plc Ordinary Shares (UK)$3.46----41.3%1742
SGL.DE SGL Carbon SE€4.89€344% above--7.1%4045
LXU LSB Industries Inc. Common Stock$9.89$826% above19.5x7.1%3845

Sector report card

Where ASIX ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Oct 6, 2026
    AdvanSix to Release Third Quarter Financial Results and Hold Investor Conference Call on November 4
  • Business Wire•Jul 7, 2026
    AdvanSix to Release Second Quarter Financial Results and Hold Investor Conference Call on August 7
  • Business Wire•May 8, 2026
    AdvanSix Announces First Quarter 2026 Financial Results
2 more press releases · full archive on Investor+.INVESTOR
37 filings of 40
October 2026
Oct 8
Form 4Insider transactionPeriod 2026-10-06
View on SEC →
August 2026
Aug 17
8-KCurrent reportPeriod 2026-08-14
View on SEC →
Aug 7
8-KCurrent reportPeriod 2026-08-07
View on SEC →
34 more filings + AI summaries on Investor+.INVESTOR